Tumor cells engineered to overexpress molecules that activate an immune response have shown therapeutic promise in preventing growth of cancers. In a new study, tumor cells studded with a ligand-mimicking antibody fragment beckon their own destruction.
|Original language||English (US)|
|Number of pages||2|
|State||Published - 2002|
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)